Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • juvenus

Become part of the latest trend in aesthetic medicine

    • Dermatology and venereology
    • RX
  • 3 minute read

Polymerized polynucleotides are currently the talk of the town when it comes to skin rejuvenation from within. Croma-Pharma proudly presents juvenus. Excellent PDRN fillers with anti-aging effect. 

Croma-Pharma presents juvenus , a new injection gel based on polymerized polynucleotides for hydration of the skin and restoration of tissue elasticity

Croma-Pharma has expanded its product portfolio in the field of aesthetics with the medical product juvenus* . It is an absorbable injection gel based on polymerized polynucleotides (PDRN)[1],[2] of natural origin to hydrate the skin and restore tissue elasticity. juvenus is easy to inject, uniquely designed and specially developed to treat different skin needs on the face and body with quickly visible results. 

Innovative approach to combat various signs of skin aging
juvenus, thanks to its special biochemical properties, increases the elasticity of the skin and effectively corrects various signs of natural and photoaging, such as wrinkles or loss of firmness and tone. Furthermore, fibrous tissue changes, such as scars, can be treated effectively. 

High-molecular-weight polynucleotides (PDRN) have a positive effect on the skin in many ways: 

  • Antioxidant effect: enzyme-induced degradation of polynucleotide molecules may lead to enhanced protection against free radicals. [3]
  • Hydration: Due to their hydrophilic and polyanionic properties, the polymerized polynucleotides contribute to the binding of water molecules, resulting in intense hydration of the tissue. Intradermal spaces are filled and the tissue becomes firmer.
  • Fibroblast growth: The intense hydration as well as the antioxidant effect create an optimal physiological environment for stimulating the metabolic activity of fibroblasts. This favors the restoration of tissue elasticity. [4]

Two concentrations for different skin needs
juvenus is available in two concentrations and is suitable for all skin types and age groups:

  • juvenus medium, PDRN 20 mg/ml: little pronounced wrinkles, such as superficial perioral wrinkles, wrinkles on the cheeks, medium scars. 

  • juvenus strong, PDRN 25 mg/ml: medium to deep wrinkles and larger body areas, such as neck, back of hands, abdomen, décolleté, thighs and buttocks, and deep/large scars.

Wide range of indications for facial and body treatments and good safety profile
The range of applications of juvenus is broadly defined and ranges from the treatment of facial wrinkles to the treatment of larger areas of the body.

juvenus has a good safety profile due to the extraction and purification of polynucleotides at high temperature. This process makes it possible to obtain a more than 95 percent pure active ingredient with inactivated proteins and peptides. This in turn guarantees the safety of the product and the absence of immunological side effects. 

“Croma always strives to bring exceptional products to market that meet the growing demands of our customers. With juvenus, we can offer a new and safe injectable that specifically combats the signs of skin aging with an innovative approach to action,” comments Managing Director Andreas Prinz.  

About Croma 
Founded in 1976, Croma-Pharma GmbH (Croma) is an Austrian family-owned company specializing in the industrial production of hyaluronic acid syringes for medical aesthetics, ophthalmology and orthopedics. Croma currently operates 12 international sales companies and distributes its products in more than 70 countries. Within its worldwide distribution network, Croma focuses on minimally invasive aesthetic medicine with its own branded products.  In addition to a wide range of HA fillers from its own production facility in Leobendorf, Croma sells PDO lifting threads, a platelet rich plasma system (PRP) and innovative skin care technologies in its strategic core markets. 

 

For more information please visit 

www.croma.ch

info@croma.ch

+41 52 633 0090

 

You would like to contact Croma-Pharma? Click here

 


[1] Müller Esterl, Biochemistry. 1st edition 2004, Elsevier

[2] Squadrito F, Bitto A, Irrera N, Pizzino G, Pallio G, Minutoli L and Altavilla D (2017) Pharmacological Activity and Clinical Use of PDRN. Front. Pharmacol. 8:224. doi: 10.3389/fphar.2017.00224

[3] Cavallini M, Papagni M. Long chain polynucleotides gel and skin biorevitalization. Int J Plast Dermatol 2007; 3: 27-32.

[4] Pak CS, Lee J, Lee H, et al. A phase III, randomized, double-blind, matched-pairs, active-controlled clinical trial and preclinical animal study to compare the durability, efficacy and safety between polynucleotide filler and hyaluronic acid filler in the correction of crow’s feet: a new concept of regenerative filler. J Korean Med Sci 2014: 29: 201- 209.

 

Partner
  • unbenannt
Previous Article
  • Quality standards in healthcare

Better outcomes through patient blood management (PBM).

  • Anesthesiology
  • Emergency and intensive care medicine
  • General Internal Medicine
  • RX
View Post
Next Article
  • Biomarker-based stratification

Prediction of the therapy response of atopic patients

  • Allergology and clinical immunology
  • Congress Reports
  • Dermatology and venereology
  • Genetics
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
View Post
  • 9 min
  • Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CA)

Diagnosis at an early stage, prognostic classifications and outlook

    • Cardiology
    • Education
    • RX
    • Studies
View Post
  • 4 min
  • Case report: Drug-induced hepatitis

Rare side effect of tirzepatide therapy

    • Cases
    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 4 min
  • Plea for sex-specific neurology

Migraine in men: underdiagnosed, underestimated, under-researched

    • Education
    • Neurology
    • RX
    • Studies
View Post
  • 4 min
  • Prurigo nodularis

Retrospective analyses of large data sets from everyday practice

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.